Journal Article

Common variants in mismatch repair genes and risk of invasive ovarian cancer

Honglin Song, Susan J. Ramus, Lydia Quaye, Richard A. DiCioccio, Jonathan Tyrer, Emma Lomas, Danielle Shadforth, Estrid Hogdall, Claus Hogdall, Valerie McGuire, Alice S. Whittemore, Douglas F. Easton, Bruce A.J. Ponder, Susanne Kruger Kjaer, Paul D.P. Pharoah and Simon A. Gayther

in Carcinogenesis

Volume 27, issue 11, pages 2235-2242
ISSN: 0143-3334
Published online June 2006 | e-ISSN: 1460-2180 | DOI: http://dx.doi.org/10.1093/carcin/bgl089
Common variants in mismatch repair genes and risk of invasive ovarian cancer

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics

GO

Show Summary Details

Preview

Mismatch repair (MMR) is important for repairing of nucleotide mismatches during DNA replication. Germline mutations in MMR genes are associated with hereditary non-polyposis colorectal cancer (HNPCC). Ovarian cancer occurs as part of the HNPCC phenotype, and so common variants in MMR genes are candidates for ovarian cancer susceptibility. We performed a large multicentre case–control study to investigate associations of common variations in MMR genes and ovarian cancer using a single nucleotide polymorphism (SNP) tagging approach. A total of 2570 controls and 1531 cases from three separate studies were genotyped for 44 tagging SNPs (stSNP) in seven MMR genes (MLH1, MLH3, MSH2, MSH3, MSH6, PMS1 and PMS2). Genotype frequencies were marginally different between cases and controls for PMS2 rs7797466 (P2df = 0.046) with a 1.17-fold (95% CI 1.03–1.33) increase in risk for each ‘a’ allele carried (P-trend = 0.013). Haplotype analysis of PMS2 also showed significant differences in frequencies between cases and controls (P7df = 0.005), with one haplotype accounting for most of the effect. There was also marginal evidence for a recessive protective effect with common homozygote as the baseline comparator for two SNPs—MSH6 rs3136245 (OR 0.67; 95% CI 0.46–0.98) and MSH3 rs6151662 (OR 0.28; 95% CI 0.08–0.91)—but the comparisons of genotype frequencies for these variants were not significant (P = 0.10 and 0.054). In conclusion, it is unlikely that common variants in MLH1, MLH3, PMS1, MSH2, MSH3 and MSH6 contribute significantly to ovarian cancer susceptibility. The observed association of PMS2 rs7797466 with ovarian cancer warrants confirmation in an independent study.

Journal Article.  7306 words. 

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.